NeoGenomics, Inc. Share Price & Technical Analysis
NEO · $9.23 (+1.32%)
Healthcare / Diagnostics & Research
$9.23
+1.32%
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to disea…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-2% return in May, 9% avg return in past 3 year May month.
-19% return in 2026, 34% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | -19% | -24% | 24% | -2% | – | – | – | – | – | – | – | -19% |
| 25 | -14% | -28% | -4% | -31% | 12% | 1% | -34% | 83% | -12% | 27% | 23% | -2% | 22% |
| 24 | -7% | 3% | 1% | -11% | -2% | 0% | 27% | -7% | -9% | -7% | 29% | -7% | 10% |
| 23 | 25% | 34% | 4% | -16% | 18% | -6% | 9% | -12% | -19% | 15% | 30% | -10% | 70% |
| 22 | -34% | -8% | -43% | -24% | -12% | -5% | 22% | 0% | -13% | -13% | 45% | -19% | -103% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.13B
P/E ratio
—
52W high
$13.74
52W low
$4.72
Volume
7,79,058
Beta
1.80
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is NeoGenomics, Inc. share price today?
- NeoGenomics, Inc. (NEO) last traded around $9.23 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NEO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NEO. Download the app for real-time alerts.
- How can I analyze NeoGenomics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.